Pharma & Healthcare
Global Bupivacaine Extended-Release Liposome Injection Market Research Report 2024
- Mar 11, 25
- ID: 3464
- Pages: 75
- Figures: 73
- Views: 21
The global market for Bupivacaine Extended-Release Liposome Injection was valued at US$ 342 million in the year 2023 and is projected to reach a revised size of US$ 468 million by 2030, growing at a CAGR of 4.6% during the forecast period.
Bupivacaine liposome injection is a special formulation that encapsulates the local anesthetic bupivacaine within liposomes. This delivery system allows for prolonged and controlled release of bupivacaine, thereby extending the duration of its anesthetic effect.
North American market for Bupivacaine Extended-Release Liposome Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bupivacaine Extended-Release Liposome Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bupivacaine Extended-Release Liposome Injection include Pacira Pharmaceuticals, Jiangsu Hengrui Pharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bupivacaine Extended-Release Liposome Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bupivacaine Extended-Release Liposome Injection.
The Bupivacaine Extended-Release Liposome Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bupivacaine Extended-Release Liposome Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bupivacaine Extended-Release Liposome Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pacira Pharmaceuticals
Jiangsu Hengrui Pharm
by Type
133mg Per Vial
266mg Per Vial
by Application
Local Anesthesia
Postoperative Analgesia
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bupivacaine Extended-Release Liposome Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bupivacaine Extended-Release Liposome Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Bupivacaine liposome injection is a special formulation that encapsulates the local anesthetic bupivacaine within liposomes. This delivery system allows for prolonged and controlled release of bupivacaine, thereby extending the duration of its anesthetic effect.
North American market for Bupivacaine Extended-Release Liposome Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bupivacaine Extended-Release Liposome Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bupivacaine Extended-Release Liposome Injection include Pacira Pharmaceuticals, Jiangsu Hengrui Pharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bupivacaine Extended-Release Liposome Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bupivacaine Extended-Release Liposome Injection.
The Bupivacaine Extended-Release Liposome Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bupivacaine Extended-Release Liposome Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bupivacaine Extended-Release Liposome Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pacira Pharmaceuticals
Jiangsu Hengrui Pharm
by Type
133mg Per Vial
266mg Per Vial
by Application
Local Anesthesia
Postoperative Analgesia
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bupivacaine Extended-Release Liposome Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bupivacaine Extended-Release Liposome Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Bupivacaine Extended-Release Liposome Injection Market Overview
1.1 Product Definition
1.2 Bupivacaine Extended-Release Liposome Injection by Type
1.2.1 Global Bupivacaine Extended-Release Liposome Injection Market Value Comparison by Type (2024-2030)
1.2.2 133mg Per Vial
1.2.3 266mg Per Vial
1.3 Bupivacaine Extended-Release Liposome Injection by Application
1.3.1 Global Bupivacaine Extended-Release Liposome Injection Market Value by Application (2024-2030)
1.3.2 Local Anesthesia
1.3.3 Postoperative Analgesia
1.3.4 Other
1.4 Global Bupivacaine Extended-Release Liposome Injection Market Size Estimates and Forecasts
1.4.1 Global Bupivacaine Extended-Release Liposome Injection Revenue 2019-2030
1.4.2 Global Bupivacaine Extended-Release Liposome Injection Sales 2019-2030
1.4.3 Global Bupivacaine Extended-Release Liposome Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bupivacaine Extended-Release Liposome Injection Market Competition by Manufacturers
2.1 Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bupivacaine Extended-Release Liposome Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Bupivacaine Extended-Release Liposome Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Product Type & Application
2.7 Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Date of Enter into This Industry
2.8 Global Bupivacaine Extended-Release Liposome Injection Market Competitive Situation and Trends
2.8.1 Global Bupivacaine Extended-Release Liposome Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bupivacaine Extended-Release Liposome Injection Players Market Share by Revenue
2.8.3 Global Bupivacaine Extended-Release Liposome Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bupivacaine Extended-Release Liposome Injection Market Scenario by Region
3.1 Global Bupivacaine Extended-Release Liposome Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bupivacaine Extended-Release Liposome Injection Sales by Region: 2019-2030
3.2.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Region: 2019-2024
3.2.2 Global Bupivacaine Extended-Release Liposome Injection Sales by Region: 2025-2030
3.3 Global Bupivacaine Extended-Release Liposome Injection Revenue by Region: 2019-2030
3.3.1 Global Bupivacaine Extended-Release Liposome Injection Revenue by Region: 2019-2024
3.3.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Region: 2025-2030
3.4 North America Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Country
3.4.1 North America Bupivacaine Extended-Release Liposome Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2030)
3.4.3 North America Bupivacaine Extended-Release Liposome Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Country
3.5.1 Europe Bupivacaine Extended-Release Liposome Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2030)
3.5.3 Europe Bupivacaine Extended-Release Liposome Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Bupivacaine Extended-Release Liposome Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bupivacaine Extended-Release Liposome Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Country
3.7.1 Latin America Bupivacaine Extended-Release Liposome Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2030)
3.7.3 Latin America Bupivacaine Extended-Release Liposome Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Bupivacaine Extended-Release Liposome Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Type (2019-2030)
4.1.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Type (2019-2024)
4.1.2 Global Bupivacaine Extended-Release Liposome Injection Sales by Type (2025-2030)
4.1.3 Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Type (2019-2030)
4.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Type (2019-2030)
4.2.1 Global Bupivacaine Extended-Release Liposome Injection Revenue by Type (2019-2024)
4.2.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Type (2025-2030)
4.2.3 Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Type (2019-2030)
4.3 Global Bupivacaine Extended-Release Liposome Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Application (2019-2030)
5.1.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Application (2019-2024)
5.1.2 Global Bupivacaine Extended-Release Liposome Injection Sales by Application (2025-2030)
5.1.3 Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Application (2019-2030)
5.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Application (2019-2030)
5.2.1 Global Bupivacaine Extended-Release Liposome Injection Revenue by Application (2019-2024)
5.2.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Application (2025-2030)
5.2.3 Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Application (2019-2030)
5.3 Global Bupivacaine Extended-Release Liposome Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pacira Pharmaceuticals
6.1.1 Pacira Pharmaceuticals Company Information
6.1.2 Pacira Pharmaceuticals Description and Business Overview
6.1.3 Pacira Pharmaceuticals Bupivacaine Extended-Release Liposome Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pacira Pharmaceuticals Bupivacaine Extended-Release Liposome Injection Product Portfolio
6.1.5 Pacira Pharmaceuticals Recent Developments/Updates
6.2 Jiangsu Hengrui Pharm
6.2.1 Jiangsu Hengrui Pharm Company Information
6.2.2 Jiangsu Hengrui Pharm Description and Business Overview
6.2.3 Jiangsu Hengrui Pharm Bupivacaine Extended-Release Liposome Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jiangsu Hengrui Pharm Bupivacaine Extended-Release Liposome Injection Product Portfolio
6.2.5 Jiangsu Hengrui Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bupivacaine Extended-Release Liposome Injection Industry Chain Analysis
7.2 Bupivacaine Extended-Release Liposome Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bupivacaine Extended-Release Liposome Injection Production Mode & Process
7.4 Bupivacaine Extended-Release Liposome Injection Sales and Marketing
7.4.1 Bupivacaine Extended-Release Liposome Injection Sales Channels
7.4.2 Bupivacaine Extended-Release Liposome Injection Distributors
7.5 Bupivacaine Extended-Release Liposome Injection Customers
8 Bupivacaine Extended-Release Liposome Injection Market Dynamics
8.1 Bupivacaine Extended-Release Liposome Injection Industry Trends
8.2 Bupivacaine Extended-Release Liposome Injection Market Drivers
8.3 Bupivacaine Extended-Release Liposome Injection Market Challenges
8.4 Bupivacaine Extended-Release Liposome Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Bupivacaine Extended-Release Liposome Injection by Type
1.2.1 Global Bupivacaine Extended-Release Liposome Injection Market Value Comparison by Type (2024-2030)
1.2.2 133mg Per Vial
1.2.3 266mg Per Vial
1.3 Bupivacaine Extended-Release Liposome Injection by Application
1.3.1 Global Bupivacaine Extended-Release Liposome Injection Market Value by Application (2024-2030)
1.3.2 Local Anesthesia
1.3.3 Postoperative Analgesia
1.3.4 Other
1.4 Global Bupivacaine Extended-Release Liposome Injection Market Size Estimates and Forecasts
1.4.1 Global Bupivacaine Extended-Release Liposome Injection Revenue 2019-2030
1.4.2 Global Bupivacaine Extended-Release Liposome Injection Sales 2019-2030
1.4.3 Global Bupivacaine Extended-Release Liposome Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bupivacaine Extended-Release Liposome Injection Market Competition by Manufacturers
2.1 Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bupivacaine Extended-Release Liposome Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Bupivacaine Extended-Release Liposome Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Product Type & Application
2.7 Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Date of Enter into This Industry
2.8 Global Bupivacaine Extended-Release Liposome Injection Market Competitive Situation and Trends
2.8.1 Global Bupivacaine Extended-Release Liposome Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bupivacaine Extended-Release Liposome Injection Players Market Share by Revenue
2.8.3 Global Bupivacaine Extended-Release Liposome Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bupivacaine Extended-Release Liposome Injection Market Scenario by Region
3.1 Global Bupivacaine Extended-Release Liposome Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bupivacaine Extended-Release Liposome Injection Sales by Region: 2019-2030
3.2.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Region: 2019-2024
3.2.2 Global Bupivacaine Extended-Release Liposome Injection Sales by Region: 2025-2030
3.3 Global Bupivacaine Extended-Release Liposome Injection Revenue by Region: 2019-2030
3.3.1 Global Bupivacaine Extended-Release Liposome Injection Revenue by Region: 2019-2024
3.3.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Region: 2025-2030
3.4 North America Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Country
3.4.1 North America Bupivacaine Extended-Release Liposome Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2030)
3.4.3 North America Bupivacaine Extended-Release Liposome Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Country
3.5.1 Europe Bupivacaine Extended-Release Liposome Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2030)
3.5.3 Europe Bupivacaine Extended-Release Liposome Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Bupivacaine Extended-Release Liposome Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bupivacaine Extended-Release Liposome Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Country
3.7.1 Latin America Bupivacaine Extended-Release Liposome Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2030)
3.7.3 Latin America Bupivacaine Extended-Release Liposome Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Bupivacaine Extended-Release Liposome Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Type (2019-2030)
4.1.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Type (2019-2024)
4.1.2 Global Bupivacaine Extended-Release Liposome Injection Sales by Type (2025-2030)
4.1.3 Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Type (2019-2030)
4.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Type (2019-2030)
4.2.1 Global Bupivacaine Extended-Release Liposome Injection Revenue by Type (2019-2024)
4.2.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Type (2025-2030)
4.2.3 Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Type (2019-2030)
4.3 Global Bupivacaine Extended-Release Liposome Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Application (2019-2030)
5.1.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Application (2019-2024)
5.1.2 Global Bupivacaine Extended-Release Liposome Injection Sales by Application (2025-2030)
5.1.3 Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Application (2019-2030)
5.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Application (2019-2030)
5.2.1 Global Bupivacaine Extended-Release Liposome Injection Revenue by Application (2019-2024)
5.2.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Application (2025-2030)
5.2.3 Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Application (2019-2030)
5.3 Global Bupivacaine Extended-Release Liposome Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pacira Pharmaceuticals
6.1.1 Pacira Pharmaceuticals Company Information
6.1.2 Pacira Pharmaceuticals Description and Business Overview
6.1.3 Pacira Pharmaceuticals Bupivacaine Extended-Release Liposome Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pacira Pharmaceuticals Bupivacaine Extended-Release Liposome Injection Product Portfolio
6.1.5 Pacira Pharmaceuticals Recent Developments/Updates
6.2 Jiangsu Hengrui Pharm
6.2.1 Jiangsu Hengrui Pharm Company Information
6.2.2 Jiangsu Hengrui Pharm Description and Business Overview
6.2.3 Jiangsu Hengrui Pharm Bupivacaine Extended-Release Liposome Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jiangsu Hengrui Pharm Bupivacaine Extended-Release Liposome Injection Product Portfolio
6.2.5 Jiangsu Hengrui Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bupivacaine Extended-Release Liposome Injection Industry Chain Analysis
7.2 Bupivacaine Extended-Release Liposome Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bupivacaine Extended-Release Liposome Injection Production Mode & Process
7.4 Bupivacaine Extended-Release Liposome Injection Sales and Marketing
7.4.1 Bupivacaine Extended-Release Liposome Injection Sales Channels
7.4.2 Bupivacaine Extended-Release Liposome Injection Distributors
7.5 Bupivacaine Extended-Release Liposome Injection Customers
8 Bupivacaine Extended-Release Liposome Injection Market Dynamics
8.1 Bupivacaine Extended-Release Liposome Injection Industry Trends
8.2 Bupivacaine Extended-Release Liposome Injection Market Drivers
8.3 Bupivacaine Extended-Release Liposome Injection Market Challenges
8.4 Bupivacaine Extended-Release Liposome Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Bupivacaine Extended-Release Liposome Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Bupivacaine Extended-Release Liposome Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Bupivacaine Extended-Release Liposome Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Bupivacaine Extended-Release Liposome Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Bupivacaine Extended-Release Liposome Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Bupivacaine Extended-Release Liposome Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Product Type & Application
Table 12. Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bupivacaine Extended-Release Liposome Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bupivacaine Extended-Release Liposome Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bupivacaine Extended-Release Liposome Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Bupivacaine Extended-Release Liposome Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Region (2019-2024)
Table 19. Global Bupivacaine Extended-Release Liposome Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Region (2025-2030)
Table 21. Global Bupivacaine Extended-Release Liposome Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Bupivacaine Extended-Release Liposome Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Bupivacaine Extended-Release Liposome Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Bupivacaine Extended-Release Liposome Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Bupivacaine Extended-Release Liposome Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Bupivacaine Extended-Release Liposome Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Bupivacaine Extended-Release Liposome Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Bupivacaine Extended-Release Liposome Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Bupivacaine Extended-Release Liposome Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Bupivacaine Extended-Release Liposome Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Bupivacaine Extended-Release Liposome Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Bupivacaine Extended-Release Liposome Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bupivacaine Extended-Release Liposome Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Bupivacaine Extended-Release Liposome Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Bupivacaine Extended-Release Liposome Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Type (2019-2024)
Table 53. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Type (2025-2030)
Table 54. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Application (2019-2024)
Table 63. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Application (2025-2030)
Table 64. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Pacira Pharmaceuticals Company Information
Table 71. Pacira Pharmaceuticals Description and Business Overview
Table 72. Pacira Pharmaceuticals Bupivacaine Extended-Release Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pacira Pharmaceuticals Bupivacaine Extended-Release Liposome Injection Product
Table 74. Pacira Pharmaceuticals Recent Developments/Updates
Table 75. Jiangsu Hengrui Pharm Company Information
Table 76. Jiangsu Hengrui Pharm Description and Business Overview
Table 77. Jiangsu Hengrui Pharm Bupivacaine Extended-Release Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Jiangsu Hengrui Pharm Bupivacaine Extended-Release Liposome Injection Product
Table 79. Jiangsu Hengrui Pharm Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Bupivacaine Extended-Release Liposome Injection Distributors List
Table 83. Bupivacaine Extended-Release Liposome Injection Customers List
Table 84. Bupivacaine Extended-Release Liposome Injection Market Trends
Table 85. Bupivacaine Extended-Release Liposome Injection Market Drivers
Table 86. Bupivacaine Extended-Release Liposome Injection Market Challenges
Table 87. Bupivacaine Extended-Release Liposome Injection Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report
List of Figures
Figure 1. Product Picture of Bupivacaine Extended-Release Liposome Injection
Figure 2. Global Bupivacaine Extended-Release Liposome Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Bupivacaine Extended-Release Liposome Injection Market Share by Type: 2023 & 2030
Figure 4. 133mg Per Vial Product Picture
Figure 5. 266mg Per Vial Product Picture
Figure 6. Global Bupivacaine Extended-Release Liposome Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Bupivacaine Extended-Release Liposome Injection Market Share by Application: 2023 & 2030
Figure 8. Local Anesthesia
Figure 9. Postoperative Analgesia
Figure 10. Other
Figure 11. Global Bupivacaine Extended-Release Liposome Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Bupivacaine Extended-Release Liposome Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Bupivacaine Extended-Release Liposome Injection Sales (2019-2030) & (K Units)
Figure 14. Global Bupivacaine Extended-Release Liposome Injection Average Price (US$/Unit) & (2019-2030)
Figure 15. Bupivacaine Extended-Release Liposome Injection Report Years Considered
Figure 16. Bupivacaine Extended-Release Liposome Injection Sales Share by Manufacturers in 2023
Figure 17. Global Bupivacaine Extended-Release Liposome Injection Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Bupivacaine Extended-Release Liposome Injection Players: Market Share by Revenue in Bupivacaine Extended-Release Liposome Injection in 2023
Figure 19. Bupivacaine Extended-Release Liposome Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Bupivacaine Extended-Release Liposome Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Bupivacaine Extended-Release Liposome Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Bupivacaine Extended-Release Liposome Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Bupivacaine Extended-Release Liposome Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Bupivacaine Extended-Release Liposome Injection Sales Market Share by Country (2019-2030)
Figure 42. Mexico Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Bupivacaine Extended-Release Liposome Injection by Type (2019-2030)
Figure 52. Global Revenue Market Share of Bupivacaine Extended-Release Liposome Injection by Type (2019-2030)
Figure 53. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Bupivacaine Extended-Release Liposome Injection by Application (2019-2030)
Figure 55. Global Revenue Market Share of Bupivacaine Extended-Release Liposome Injection by Application (2019-2030)
Figure 56. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Application (2019-2030)
Figure 57. Bupivacaine Extended-Release Liposome Injection Value Chain
Figure 58. Bupivacaine Extended-Release Liposome Injection Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Bupivacaine Extended-Release Liposome Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Bupivacaine Extended-Release Liposome Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Bupivacaine Extended-Release Liposome Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Bupivacaine Extended-Release Liposome Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Bupivacaine Extended-Release Liposome Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Bupivacaine Extended-Release Liposome Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Product Type & Application
Table 12. Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bupivacaine Extended-Release Liposome Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bupivacaine Extended-Release Liposome Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bupivacaine Extended-Release Liposome Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Bupivacaine Extended-Release Liposome Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Region (2019-2024)
Table 19. Global Bupivacaine Extended-Release Liposome Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Region (2025-2030)
Table 21. Global Bupivacaine Extended-Release Liposome Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Bupivacaine Extended-Release Liposome Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Bupivacaine Extended-Release Liposome Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Bupivacaine Extended-Release Liposome Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Bupivacaine Extended-Release Liposome Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Bupivacaine Extended-Release Liposome Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Bupivacaine Extended-Release Liposome Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Bupivacaine Extended-Release Liposome Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Bupivacaine Extended-Release Liposome Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Bupivacaine Extended-Release Liposome Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Bupivacaine Extended-Release Liposome Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Bupivacaine Extended-Release Liposome Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bupivacaine Extended-Release Liposome Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Bupivacaine Extended-Release Liposome Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Bupivacaine Extended-Release Liposome Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Type (2019-2024)
Table 53. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Type (2025-2030)
Table 54. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Application (2019-2024)
Table 63. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Application (2025-2030)
Table 64. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Pacira Pharmaceuticals Company Information
Table 71. Pacira Pharmaceuticals Description and Business Overview
Table 72. Pacira Pharmaceuticals Bupivacaine Extended-Release Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pacira Pharmaceuticals Bupivacaine Extended-Release Liposome Injection Product
Table 74. Pacira Pharmaceuticals Recent Developments/Updates
Table 75. Jiangsu Hengrui Pharm Company Information
Table 76. Jiangsu Hengrui Pharm Description and Business Overview
Table 77. Jiangsu Hengrui Pharm Bupivacaine Extended-Release Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Jiangsu Hengrui Pharm Bupivacaine Extended-Release Liposome Injection Product
Table 79. Jiangsu Hengrui Pharm Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Bupivacaine Extended-Release Liposome Injection Distributors List
Table 83. Bupivacaine Extended-Release Liposome Injection Customers List
Table 84. Bupivacaine Extended-Release Liposome Injection Market Trends
Table 85. Bupivacaine Extended-Release Liposome Injection Market Drivers
Table 86. Bupivacaine Extended-Release Liposome Injection Market Challenges
Table 87. Bupivacaine Extended-Release Liposome Injection Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report
List of Figures
Figure 1. Product Picture of Bupivacaine Extended-Release Liposome Injection
Figure 2. Global Bupivacaine Extended-Release Liposome Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Bupivacaine Extended-Release Liposome Injection Market Share by Type: 2023 & 2030
Figure 4. 133mg Per Vial Product Picture
Figure 5. 266mg Per Vial Product Picture
Figure 6. Global Bupivacaine Extended-Release Liposome Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Bupivacaine Extended-Release Liposome Injection Market Share by Application: 2023 & 2030
Figure 8. Local Anesthesia
Figure 9. Postoperative Analgesia
Figure 10. Other
Figure 11. Global Bupivacaine Extended-Release Liposome Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Bupivacaine Extended-Release Liposome Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Bupivacaine Extended-Release Liposome Injection Sales (2019-2030) & (K Units)
Figure 14. Global Bupivacaine Extended-Release Liposome Injection Average Price (US$/Unit) & (2019-2030)
Figure 15. Bupivacaine Extended-Release Liposome Injection Report Years Considered
Figure 16. Bupivacaine Extended-Release Liposome Injection Sales Share by Manufacturers in 2023
Figure 17. Global Bupivacaine Extended-Release Liposome Injection Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Bupivacaine Extended-Release Liposome Injection Players: Market Share by Revenue in Bupivacaine Extended-Release Liposome Injection in 2023
Figure 19. Bupivacaine Extended-Release Liposome Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Bupivacaine Extended-Release Liposome Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Bupivacaine Extended-Release Liposome Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Bupivacaine Extended-Release Liposome Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Bupivacaine Extended-Release Liposome Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Bupivacaine Extended-Release Liposome Injection Sales Market Share by Country (2019-2030)
Figure 42. Mexico Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Bupivacaine Extended-Release Liposome Injection by Type (2019-2030)
Figure 52. Global Revenue Market Share of Bupivacaine Extended-Release Liposome Injection by Type (2019-2030)
Figure 53. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Bupivacaine Extended-Release Liposome Injection by Application (2019-2030)
Figure 55. Global Revenue Market Share of Bupivacaine Extended-Release Liposome Injection by Application (2019-2030)
Figure 56. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Application (2019-2030)
Figure 57. Bupivacaine Extended-Release Liposome Injection Value Chain
Figure 58. Bupivacaine Extended-Release Liposome Injection Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232